Handelsbanken Fonder Ab Sangamo Therapeutics, Inc Transaction History

Handelsbanken Fonder Ab

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 07, 2023	BUY	$2.77 - $5.07 $41,954 - $76,790	15,146 New	15,146 $48,000
Q2 2022 Aug 03, 2022	SELL	$3.28 - $6.21 $22,960 - $43,470	-7,000 Reduced 19.86%	28,246 $117,000
Q2 2021 Aug 03, 2021	BUY	$10.17 - $12.64 $181,026 - $224,992	17,800 Added 102.03%	35,246 $422,000
Q2 2020 Aug 13, 2020	BUY	$6.21 - $11.83 $108,339 - $206,386	17,446 New	17,446 $156,000
Q2 2019 Jul 12, 2019	SELL	$8.75 - $13.03 $831,250 - $1.24 Million	-95,000 Closed	0 $0
Q4 2018 Jan 31, 2019	SELL	$9.51 - $16.6 $4.28 Million - $7.47 Million	-450,000 Reduced 82.57%	95,000 $1.09 Million
Q3 2018 Oct 23, 2018	BUY	$13.05 - $19.05 $7.11 Million - $10.4 Million	545,000 New	545,000 $9.24 Million
Q3 2018 Oct 19, 2018	SELL	$13.05 - $19.05 $4.66 Million - $6.8 Million	-357,000 Closed	0 $0
Q2 2018 Jul 11, 2018	BUY	$13.9 - $19.8 $4.96 Million - $7.07 Million	357,000 New	357,000 $5.07 Million

111

56.4M

576K

1.17M

Ticker SGMO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 156,552,992
Market Cap $180M
Description
Sangamo Therapeutics, Inc., a clinical-stage biotechnology company, focuses on translating science into genomic medicines that transform patients' lives using platform technologies in gene therapy, cell therapy, genome editing, and genome regulation. The company offers zinc finger protein (ZFP), a technology platform for making zinc finger nucle...

Get notified when there are updates to the investment portfolio of Handelsbanken Fonder Ab, based on Form 13F filings with the SEC.

Stay updated on Handelsbanken Fonder Ab with notifications on news.